Chinese Hepatolgy ›› 2026, Vol. 31 ›› Issue (9): 1232-1235.
• Liver Fibrosis and Cirrhosis • Previous Articles Next Articles
Wang Yiru, Ding Lei, Meng Fankun
Received:2025-11-04
Online:2026-09-30
Published:2026-11-16
Contact:
Meng Fankun, Email: mengfankun818@126.com
Wang Yiru, Ding Lei, Meng Fankun. The clinical application value of combined measurement of liver and spleen stiffness in non-invasive assessment of fibrosis stages in chronic hepatitis B[J]. Chinese Hepatolgy, 2026, 31(9): 1232-1235.
| [1] Pollicino T, Caminiti G. HBV-integration studies in the clinic: role in the natural history of infection[J]. Viruses, 2021,13(3)368. [2] Alberts C J, Clifford G M, Georges D, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review[J]. Lancet Gastroenterol Hepatol, 2022,7(8):724-735. [3] Jühling F, Saviano A, Ponsolles C, et al. Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma[J]. Life Sci Alliance, 2021,4(9):e202101036. [4] 尤红, 王福生, 李太生, 等. 慢性乙型肝炎防治指南(2022年版)[J]. 实用肝脏病杂志, 2023,26(3):457-478. [5] Cai X, Liu X, Xie W, et al. Hydronidone for the treatment of liver fibrosis related to chronic hepatitis B: a phase 2 randomized controlled trial[J]. Clin Gastroenterol Hepatol, 2023,21(7):1893-1901. [6] Tsai N C, Marcellin P, Buti M, et al. Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B[J]. Dig Dis Sci, 2015,60(1):260-268. [7] Zhao Z M, Zhu C W, Huang J Q, et al. Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: a single arm clinical objective performance criteria trial[J]. J Ethnopharmacol, 2022,298:115599. [8] 尤红, 陈永鹏. 瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版)[J]. 中华肝脏病杂志, 2019,27(3):182-191. [9] 陆伦根, 尤红, 谢渭芬, 等. 肝纤维化诊断及治疗共识(2019年)[J]. 实用肝脏病杂志, 2019,22(6):793-803. [10] Unalp-Arida A, Ruhl C E. Transient elastography-assessed hepatic steatosis and fibrosis are associated with body composition in the United States[J]. Clin Gastroenterol Hepatol, 2022,20(4):e808-e830. [11] Porubcin S, Rovnakova A, Zahornacky O, et al. Correlation of gallbladder wall pathology with controlled attenuation parameter, liver stiffness measurement, and laboratory markers in acute viral hepatitis A[J]. Ultrasound, 2025:1742271X-251356613X. [12] Janik M K, Kruk B, Szczepankiewicz B, et al. Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis[J]. Liver Int, 2021,41(2):348-356. [13] Zhang W, Wang J, Linghu R, et al. Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study[J]. Eur Radiol, 2022,32(7):4980-4990. [14] Dong B T, Huang S, Lyu G R, et al. Assessment of liver fibrosis with liver and spleen stiffness measured by sound touch elastography, serum fibrosis markers in patients with chronic hepatitis B[J]. J Dig Dis, 2021,22(6):342-350. [15] Son J H, Lee S S, Lee Y, et al. Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease[J]. Eur Radiol, 2020,30(6):3486-3496. [16] Zheng C J, Huang H, Xiao B H, et al. Spleen in viral hepatitis-B liver fibrosis patients may have a reduced level of per unit micro-circulation: non-invasive diffusion MRI evidence with a surrogate marker[J]. SLAS Technol, 2022,27(3):187-194. [17] Dietrich C F, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)[J]. Ultraschall Med, 2017,38(4):e16-e47. [18] 张晶,王泰龄,刘霞,等. 慢性肝炎炎症活动度及纤维化程度计分方案[J]. 中华肝脏病杂志, 1998,6(4):195-197. [19] Larino-Noia J, Fernandez-Castroagudin J, de la Iglesia-Garcia D, et al. Quality of tissue samples obtained by endoscopic ultrasound-guided liver biopsy: a randomized, controlled clinical trial[J]. Am J Gastroenterol, 2023,118(10):1821-1828. [20] Hollerbach S, Willert J, Topalidis T, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment[J]. Endoscopy, 2003,35(9):743-749. [21] Rousselet M C, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis[J]. Hepatology, 2005,41(2):257-264. [22] Rockey D C, Caldwell S H, Goodman Z D, et al. Liver biopsy[J]. Hepatology, 2009,49(3):1017-1044. [23] Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease[J]. Gastroenterology, 2005,128(7):1898-1906. [24] Hu X, Xu X, Zhang Q, et al. Indirect prediction of liver fibrosis by quantitative measurement of spleen stiffness using the FibroScan system[J]. J Ultrasound Med, 2014,33(1):73-81. [25] Wang J, Cao L, Liu F, et al. A multi-institutional study on ultrasound image analysis for staging HBV-derived liver fibrosis: a potential noninvasive alternative to liver stiffness measurement[J]. Clin Transl Gastroenterol, 2024,15(12):e780. [26] Liguori A, Zoncape M, Casazza G, et al. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2025,10(4):332-349. [27] 段良良, 白宝艳, 王胜利, 等. 声触诊弹性成像检测肝脾硬度联合APRI、FIB-4评估慢性乙型肝炎肝纤维化程度的价值[J]. 肝脏, 2025,30(6):789-792. [28] 卢秋燕, 卢燕辉, 徐成润. 瞬时弹性成像检测肝硬度联合脾硬度对慢性乙型肝炎肝纤维化诊断的价值[J]. 肝脏, 2023,28(3):325-329. [29] 张雨. 世界卫生组织《慢性乙型肝炎预防、诊断、关怀及治疗指南(2024年版)》解读[J/OL]. 中华实验和临床感染病杂志(电子版), 2024,18(3):191-192. https://rs.yiigle.com/cmaid/1567422 [30] Xing Y, Zhong W, Peng D, et al. Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: a multicenter, randomized clinical trial[J]. Pharmacol Res, 2023,190:106737. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||